Institution
University of Warwick
Education•Coventry, Warwickshire, United Kingdom•
About: University of Warwick is a education organization based out in Coventry, Warwickshire, United Kingdom. It is known for research contribution in the topics: Population & White dwarf. The organization has 26212 authors who have published 77127 publications receiving 2666552 citations. The organization is also known as: Warwick University & The University of Warwick.
Topics: Population, White dwarf, Politics, Health care, Poison control
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Evidence that universal school mental health promotion programmes can be effective is provided and suggests that long‐term interventions promoting the positive mental health of all pupils and involving changes to the school climate are likely to be more successful than brief class‐based mental illness prevention programmes.
Abstract: Reviews previous studies of the universal approach to mental health promotion, and disease prevention programmes or interventions in schools. Over 8,000 publications were identified initially and 425 studies obtained for further review. The inclusion criteria were met by 17 (mostly US) studies investigating 16 interventions. Positive evidence of effectiveness was obtained for programmes that adopted a whole‐school approach, were implemented continuously for more than a year, and were aimed at the promotion of mental health as opposed to the prevention of mental illness. Provides evidence that universal school mental health promotion programmes can be effective and suggests that long‐term interventions promoting the positive mental health of all pupils and involving changes to the school climate are likely to be more successful than brief class‐based mental illness prevention programmes.
448 citations
••
TL;DR: A unified framework for a UAV-assisted emergency network is established in disasters by jointly optimized to provide wireless service to ground devices with surviving BSs and multihop UAV relaying to realize information exchange between the disaster areas and outside through optimizing the hovering positions of UAVs.
Abstract: Reliable and flexible emergency communication is a key challenge for search and rescue in the event of disasters, especially for the case when base stations are no longer functioning. Unmanned aerial vehicle (UAV)-assisted networking is emerging as a promising method to establish emergency networks. In this article, a unified framework for a UAV-assisted emergency network is established in disasters. First, the trajectory and scheduling of UAVs are jointly optimized to provide wireless service to ground devices with surviving BSs. Then the transceiver design of UAV and establishment of multihop ground device-to-device communication are studied to extend the wireless coverage of UAV. In addition, multihop UAV relaying is added to realize information exchange between the disaster areas and outside through optimizing the hovering positions of UAVs. Simulation results are presented to show the effectiveness of these three schemes. Finally, open research issues and challenges are discussed.
447 citations
••
Monash University1, University of Birmingham2, University of Oxford3, University of Alcalá4, Hull York Medical School5, National Institutes of Health6, Birmingham City Hospital7, University of Warwick8, Sahlgrenska University Hospital9, Oslo University Hospital10, University of Alberta11, Castle Hill Hospital12, University of East Anglia13
TL;DR: Based on the findings, β blockers should not be used preferentially over other rate-control medications and not regarded as standard therapy to improve prognosis in patients with concomitant heart failure and atrial fibrillation.
447 citations
••
TL;DR: This is the most precise measurement of R_{K} to date and is compatible with the standard model at the level of 2.5 standard deviations.
Abstract: A measurement of the ratio of branching fractions of the decays
B
+
→
K
+
μ
+
μ
−
and
B
+
→
K
+
e
+
e
−
is presented. The proton-proton collision data used correspond to an integrated luminosity of
5.0
fb
−
1
recorded with the LHCb experiment at center-of-mass energies of 7, 8, and 13 TeV. For the dilepton mass-squared range
1.1
<
q
2
<
6.0
GeV
2
/
c
4
the ratio of branching fractions is measured to be
R
K
=
0.84
6
+
0.060
−
0.054
+
0.016
−
0.014
, where the first uncertainty is statistical and the second systematic. This is the most precise measurement of
R
K
to date and is compatible with the standard model at the level of 2.5 standard deviations.
446 citations
••
University of Birmingham1, University of Sydney2, University of Toronto3, Medicines and Healthcare Products Regulatory Agency4, University of Washington5, University of Oxford6, University of North Carolina at Chapel Hill7, University of Leeds8, University of Warwick9, University of Bristol10, Johnson & Johnson11, Merck & Co.12, Food and Drug Administration13, Patient-Centered Outcomes Research Institute14, Queen's University15, National Cancer Research Institute16
TL;DR: The SPIRIT-PRO guidelines provide recommendations for items that should be addressed and included in clinical trial protocols in which PROs are a primary or key secondary outcome and improved design of clinical trials including PROs could help ensure high-quality data that may inform patient-centered care.
Abstract: Importance Patient-reported outcome (PRO) data from clinical trials can provide valuable evidence to inform shared decision making, labeling claims, clinical guidelines, and health policy; however, the PRO content of clinical trial protocols is often suboptimal. The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) statement was published in 2013 and aims to improve the completeness of trial protocols by providing evidence-based recommendations for the minimum set of items to be addressed, but it does not provide PRO-specific guidance. Objective To develop international, consensus-based, PRO-specific protocol guidance (the SPIRIT-PRO Extension). Design, Setting, and Participants The SPIRIT-PRO Extension was developed following the Enhancing Quality and Transparency of Health Research (EQUATOR) Network’s methodological framework for guideline development. This included (1) a systematic review of existing PRO-specific protocol guidance to generate a list of potential PRO-specific protocol items (published in 2014); (2) refinements to the list and removal of duplicate items by the International Society for Quality of Life Research (ISOQOL) Protocol Checklist Taskforce; (3) an international stakeholder survey of clinical trial research personnel, PRO methodologists, health economists, psychometricians, patient advocates, funders, industry representatives, journal editors, policy makers, ethicists, and researchers responsible for evidence synthesis (distributed by 38 international partner organizations in October 2016); (4) an international Delphi exercise (n = 137 invited; October 2016 to February 2017); and (5) consensus meeting (n = 30 invited; May 2017). Prior to voting, consensus meeting participants were informed of the results of the Delphi exercise and given data from structured reviews evaluating the PRO protocol content of 3 defined samples of trial protocols. Results The systematic review identified 162 PRO-specific protocol recommendations from 54 sources. The ISOQOL Taskforce (n = 21) reduced this to 56 items, which were considered by 138 international stakeholder survey participants and 99 Delphi panelists. The final wording of the SPIRIT-PRO Extension was agreed on at a consensus meeting (n = 29 participants) and reviewed by external group of experts during a consultation period. Eleven extensions and 5 elaborations to the SPIRIT 2013 checklist were recommended for inclusion in clinical trial protocols in which PROs are a primary or key secondary outcome. Extension items focused on PRO-specific issues relating to the trial rationale, objectives, eligibility criteria, concepts used to evaluate the intervention, time points for assessment, PRO instrument selection and measurement properties, data collection plan, translation to other languages, proxy completion, strategies to minimize missing data, and whether PRO data will be monitored during the study to inform clinical care. Conclusions and Relevance The SPIRIT-PRO guidelines provide recommendations for items that should be addressed and included in clinical trial protocols in which PROs are a primary or key secondary outcome. Improved design of clinical trials including PROs could help ensure high-quality data that may inform patient-centered care.
445 citations
Authors
Showing all 26659 results
Name | H-index | Papers | Citations |
---|---|---|---|
David Miller | 203 | 2573 | 204840 |
Daniel R. Weinberger | 177 | 879 | 128450 |
Kay-Tee Khaw | 174 | 1389 | 138782 |
Joseph E. Stiglitz | 164 | 1142 | 152469 |
Edmund T. Rolls | 153 | 612 | 77928 |
Thomas J. Smith | 140 | 1775 | 113919 |
Tim Jones | 135 | 1314 | 91422 |
Ian Ford | 134 | 678 | 85769 |
Paul Harrison | 133 | 1400 | 80539 |
Sinead Farrington | 133 | 1422 | 91099 |
Peter Hall | 132 | 1640 | 85019 |
Paul Brennan | 132 | 1221 | 72748 |
G. T. Jones | 131 | 864 | 75491 |
Peter Simmonds | 131 | 823 | 62953 |
Tim Martin | 129 | 878 | 82390 |